S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa

Avalo Therapeutics (AVTX) News Today

$0.05
-0.01 (-15.87%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.05
$0.06
50-Day Range
$0.05
$0.16
52-Week Range
$0.05
$6.09
Volume
15.41 million shs
Average Volume
14.39 million shs
Market Capitalization
$1.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SourceHeadline
finanznachrichten.de logoAvalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
finanznachrichten.de - December 7 at 8:41 AM
finance.yahoo.com logoAvalo Encourages Stockholders to Vote FOR the Reverse Stock Split
finance.yahoo.com - December 7 at 8:41 AM
MarketBeat logoAvalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Large Increase in Short Interest
americanbankingnews.com - December 1 at 4:12 AM
benzinga.com logoAvalo Therapeutics Stock (NASDAQ:AVTX) Earnings Dates and Earning Calls
benzinga.com - November 11 at 7:28 PM
morningstar.com logoAvalo Therapeutics Inc AVTX
morningstar.com - November 9 at 4:21 PM
finance.yahoo.com logoAvalo Therapeutics Inc (AVTX) Announces Q3 2023 Financial Results and Strategic Advances
finance.yahoo.com - November 9 at 11:20 AM
finance.yahoo.com logoAvalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - November 9 at 11:20 AM
finance.yahoo.com logoAvalo Completes Divestiture of AVTX-800 Series
finance.yahoo.com - October 31 at 7:47 AM
finance.yahoo.com logoBestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics
finance.yahoo.com - September 27 at 12:26 PM
benzinga.com logoWhy Avalo Therapeutics Stock Is Up Today
benzinga.com - September 26 at 3:43 PM
benzinga.com logoWhat's Going On With Avalo Therapeutics (AVTX) Stock?
benzinga.com - September 22 at 2:46 PM
benzinga.com logoWhy Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket
benzinga.com - September 18 at 9:22 AM
benzinga.com logoWhy Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
benzinga.com - September 13 at 4:25 PM
msn.com logoAvalo drops three rare disease assets amid ongoing challenges
msn.com - September 13 at 4:25 PM
benzinga.com logoWhy Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
benzinga.com - September 13 at 9:45 AM
marketwatch.com logoAvalo Therapeutics Shares Rise 53% After Deal to Divest Certain Assets
marketwatch.com - September 12 at 6:43 PM
msn.com logoWhy Microcap Biotech Firm Avalo Therapeutics Stock Is Trading Higher Today?
msn.com - September 12 at 6:43 PM
markets.businessinsider.com logoCrude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher
markets.businessinsider.com - September 12 at 6:43 PM
markets.businessinsider.com logoAvalo Therapeutics To Sell 800 Series Programs To AUG Therapeutics; Stock Surges
markets.businessinsider.com - September 12 at 7:51 AM
seekingalpha.com logoAvalo enters agreement to divest AVTX-800 series
seekingalpha.com - September 12 at 7:51 AM
finance.yahoo.com logoAvalo Enters into Agreement to Divest AVTX-800 Series
finance.yahoo.com - September 12 at 7:51 AM
finance.yahoo.com logoAvalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 6 at 10:11 AM
finance.yahoo.com logoIs Avalo Therapeutics (AVTX) A Hidden Gem or A Value Trap?
finance.yahoo.com - August 22 at 9:58 PM
msn.com logoAvalo Therapeutics, Inc. (AVTX) Reports Q2 Loss, Misses Revenue Estimates
msn.com - August 3 at 10:20 AM
finance.yahoo.com logoAvalo Reports Second Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - August 3 at 10:19 AM
benzinga.com logoAvalo Therapeutics Stock (NASDAQ:AVTX) Insider Trades
benzinga.com - July 26 at 3:48 PM
finance.yahoo.com logoAvalo to Participate in SVB Securities Therapeutics Forum
finance.yahoo.com - July 6 at 7:35 PM
benzinga.com logoAvalo Therapeutics 10% Owner Sold $1.03M In Company Stock
benzinga.com - June 28 at 4:28 PM
msn.com logoAvalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
msn.com - June 27 at 11:33 AM
msn.com logoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04%
msn.com - June 26 at 7:13 PM
msn.com logoWhy Are Avalo Therapeutics Shares Plummeting On Monday
msn.com - June 26 at 2:12 PM
msn.com logoAvalo Plummets 80% on Phase 2 Disappointment in Asthma
msn.com - June 26 at 2:12 PM
marketwatch.com logoAvalo Therapeutics Shares Hit 52-Week Low After Trial Misses Primary Endpoint
marketwatch.com - June 26 at 2:12 PM
marketbeat.com logo
marketbeat.com - June 26 at 9:35 AM
finanznachrichten.de logoAvalo Therapeutics: Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma
finanznachrichten.de - June 26 at 9:12 AM
marketwatch.com logoAvalo Therapeutics Trial for AVTX-002 Misses Primary Endpoint
marketwatch.com - June 26 at 9:12 AM
markets.businessinsider.com logoAvalo Therapeutics: AVTX-002 Fails To Meet Primary Endpoint In Phase 2 PEAK Trial
markets.businessinsider.com - June 26 at 9:12 AM
marketwatch.com logoAvalo Therapeutics Shares Drop 85% After Trial for AVTX-002 Misses Primary Endpoint
marketwatch.com - June 26 at 9:12 AM
finance.yahoo.com logoAvalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma
finance.yahoo.com - June 26 at 9:12 AM
marketbeat.com logo
marketbeat.com - June 26 at 6:59 AM
finance.yahoo.com logoAvalo to Present at the Jefferies Healthcare Conference
finance.yahoo.com - June 1 at 10:18 AM
finance.yahoo.com logoAvalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Board
finance.yahoo.com - May 22 at 8:50 AM
finanznachrichten.de logoAvalo Therapeutics: Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates
finanznachrichten.de - May 18 at 8:38 AM
benzinga.com logoChief Financial Officer at Avalo Therapeutics Acquires Company Stock Options Worth 40,000 Shares
benzinga.com - May 17 at 3:12 PM
finance.yahoo.com logoAvalo to Present at ATS 2023 Respiratory Innovation Summit
finance.yahoo.com - May 15 at 7:30 AM
finance.yahoo.com logoAvalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 10 at 8:05 AM
seekingalpha.com logoAvalo Therapeutics GAAP EPS of -$0.85, revenue of $0.48M
seekingalpha.com - May 6 at 10:39 PM
msn.com logoAvalo Therapeutics, Inc. (AVTX) Reports Q1 Loss, Lags Revenue Estimates
msn.com - May 4 at 8:30 PM
finance.yahoo.com logoAvalo Reports First Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - May 4 at 8:30 PM
finance.yahoo.com logoCambyz Golestaneh Just Bought 4.0% More Shares In Avalo Therapeutics, Inc. (NASDAQ:AVTX)
finance.yahoo.com - April 13 at 10:36 AM
Get Avalo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter.



AVTX Media Mentions By Week

AVTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVTX
News Sentiment

1.30

0.51

Average
Medical
News Sentiment

AVTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVTX Articles
This Week

2

1

AVTX Articles
Average Week

Get Avalo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AVTX) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -